JPWO2023150591A5 - - Google Patents
Info
- Publication number
- JPWO2023150591A5 JPWO2023150591A5 JP2024546231A JP2024546231A JPWO2023150591A5 JP WO2023150591 A5 JPWO2023150591 A5 JP WO2023150591A5 JP 2024546231 A JP2024546231 A JP 2024546231A JP 2024546231 A JP2024546231 A JP 2024546231A JP WO2023150591 A5 JPWO2023150591 A5 JP WO2023150591A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- halogen
- halogenated
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263306289P | 2022-02-03 | 2022-02-03 | |
| US63/306,289 | 2022-02-03 | ||
| PCT/US2023/061810 WO2023150591A2 (en) | 2022-02-03 | 2023-02-02 | Pyridazinone compounds as trpa1 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506422A JP2025506422A (ja) | 2025-03-11 |
| JPWO2023150591A5 true JPWO2023150591A5 (enExample) | 2026-02-09 |
Family
ID=87553008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546231A Pending JP2025506422A (ja) | 2022-02-03 | 2023-02-02 | Ｔｒｐａ１阻害剤としてのピリダジノン化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250154139A1 (enExample) |
| EP (1) | EP4472624A4 (enExample) |
| JP (1) | JP2025506422A (enExample) |
| CN (1) | CN118973564A (enExample) |
| AR (1) | AR128430A1 (enExample) |
| CA (1) | CA3247018A1 (enExample) |
| TW (1) | TW202339720A (enExample) |
| WO (1) | WO2023150591A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026009854A1 (ja) * | 2024-07-01 | 2026-01-08 | 日本たばこ産業株式会社 | ピリダジノン化合物及びその医薬用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007025718A1 (de) * | 2007-06-01 | 2008-12-04 | Merck Patent Gmbh | Pyridazinonderivate |
| DE102007061963A1 (de) * | 2007-12-21 | 2009-06-25 | Merck Patent Gmbh | Pyridazinonderivate |
| TWI688564B (zh) * | 2014-01-31 | 2020-03-21 | 美商必治妥美雅史谷比公司 | 作為凝血因子ｘｉａ抑制劑之具有雜環p2'基團之巨環化合物 |
| WO2017060488A1 (en) * | 2015-10-09 | 2017-04-13 | Almirall, S.A. | New trpa1 antagonists |
| WO2019104201A1 (en) * | 2017-11-21 | 2019-05-31 | Zander Therapeutics, Inc. | Small molecule agonists and antagonists of nr2f6 activity in non-humans |
| AU2019362788A1 (en) * | 2018-10-15 | 2021-04-15 | Dana-Farber Cancer Institute, Inc. | Transcriptional enhanced associate domain (TEAD) transcription factor inhibitors and uses thereof |
| JP7602061B2 (ja) * | 2021-04-14 | 2024-12-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ＴＲＰＡ１阻害剤としてのイミダゾ［４，５－ｄ］ピリダジノニル誘導体 |
-
2023
- 2023-02-02 AR ARP230100249A patent/AR128430A1/es unknown
- 2023-02-02 EP EP23750376.8A patent/EP4472624A4/en active Pending
- 2023-02-02 CN CN202380032039.9A patent/CN118973564A/zh active Pending
- 2023-02-02 TW TW112103557A patent/TW202339720A/zh unknown
- 2023-02-02 US US18/835,428 patent/US20250154139A1/en active Pending
- 2023-02-02 WO PCT/US2023/061810 patent/WO2023150591A2/en not_active Ceased
- 2023-02-02 JP JP2024546231A patent/JP2025506422A/ja active Pending
- 2023-02-02 CA CA3247018A patent/CA3247018A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69711430T2 (de) | PYRROLO[3,4-d]PYRIMIDINON-DERIVATE UND IHRE VERWENDUNG ALS IMMUNOSUPPRESSOREN | |
| JP4129286B2 (ja) | 新規チアゾリジン−４−オン誘導体 | |
| DE60003709T2 (de) | Substituierte azole | |
| JPWO2021092115A5 (enExample) | ||
| WO2000026209A1 (en) | Anti-inflammatory 4-phenyl-5-pyrimidinyl-imidazoles | |
| RU2008105345A (ru) | Производные имида индолилмалеиновой кислоты как ингибиторы протеинкиназы с | |
| RU2008133382A (ru) | Соединения гидантоина для лечения воспалительных заболеваний | |
| JP2010540508A5 (enExample) | ||
| JP2008513508A5 (enExample) | ||
| CA2900703A1 (en) | Pyrrolo [2, 3 -d]pyrimidine derivatives as inhibitors of janus- related kinases (jak) | |
| SK186599A3 (en) | 2-substituted 4,5-diaryl imidazoles, process for their preparation, pharmaceutical composition containing them and their use | |
| JP2009544620A (ja) | 自己免疫疾患及び炎症のためのプロリン尿素ｃｃｒ１アンタゴニスト | |
| SK72195A3 (en) | Oxalylamino-benzofuran and benzothiene derivatives, method of their preparation, pharmaceutical agent containing these compounds and its use | |
| JP2006507355A5 (enExample) | ||
| US5210086A (en) | 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapy | |
| EP2635573B1 (en) | Heterocyclic compounds as s1p1 agonists for the treatment of autoimmune and vascular diseases | |
| PT605228E (pt) | Derivados tiazolidinadionas sua preparacao e sua utilizacao | |
| JPH05148197A (ja) | フエノキシフエニル誘導体 | |
| US20030149021A1 (en) | Piperazine mono(dithio)carbamate ester compounds and analogs thereof: preparation method and uses thereof | |
| JP2020521739A5 (enExample) | ||
| JPWO2023150591A5 (enExample) | ||
| JPH03388B2 (enExample) | ||
| JPWO2023150592A5 (enExample) | ||
| JP7618642B2 (ja) | インターロイキンの調節におけるプロドラッグ | |
| JPWO2021071802A5 (enExample) |